Literature DB >> 14662404

Describing bladder storage function: overactive bladder syndrome and detrusor overactivity.

Paul Abrams1.   

Abstract

After a comprehensive review of terminology of lower urinary tract function/dysfunction, the International Continence Society (ICS) has recommended the use of the terms overactive bladder syndrome (OAB) and detrusor overactivity. Detrusor overactivity is defined as a urodynamic observation characterized by involuntary detrusor contractions during the filling phase that may be spontaneous or provoked. Detrusor overactivity is subdivided into idiopathic detrusor overactivity and neurogenic detrusor overactivity. Because detrusor overactivity is a urodynamic diagnosis, it is essential to record symptoms and signs during urodynamic studies to correlate them with any involuntary contractions. The ICS 2002 report describes 2 types of detrusor overactivity: (1) phasic, which may or may not lead to urinary incontinence; and (2) terminal, which is a single involuntary detrusor contraction that often results in complete bladder emptying. OAB, as defined by ICS 2002, is a new term and is a symptomatic diagnosis. OAB is defined as urgency, with or without urge incontinence, and usually with frequency and nocturia. The ICS endorsement of the term OAB recognizes that patients with this symptom syndrome are almost always treated by nonsurgical means on an empirical basis, ie, without a urodynamic confirmation of the presumed diagnosis, detrusor overactivity. The ICS believes that these terms are more intuitive and will make it easier for patients and physicians alike to understand. It is hoped that general use of the new ICS definitions will facilitate effective communications between patients and their physicians concerning their urologic dysfunctions.

Entities:  

Mesh:

Year:  2003        PMID: 14662404     DOI: 10.1016/j.urology.2003.09.050

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  57 in total

1.  Modulation of spontaneous activity in the overactive bladder: the role of P2Y agonists.

Authors:  C H Fry; J S Young; R I Jabr; C McCarthy; Y Ikeda; A J Kanai
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-22

2.  Urodynamics in the octogenarian female: is it worthwhile?

Authors:  Stephen J Bromage; Trevor J Dorkin; Lewis Chan; Vincent Tse
Journal:  Int Urogynecol J       Date:  2010-06-15       Impact factor: 2.894

Review 3.  Effectiveness of BTX-A and neuromodulation in treating OAB with or without detrusor overactivity: a systematic review.

Authors:  Suneetha Rachaneni; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2017-01-12       Impact factor: 2.894

Review 4.  [Medical combination therapy in LUTS suggestive of BPH].

Authors:  K Höfner; M Oelke
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

Review 5.  Augmentation cystoplasty: what are the indications?

Authors:  Polina Reyblat; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

6.  Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.

Authors:  Miao Yan; Peng Xue; Kunpeng Wang; Guojun Gao; Wei Zhang; Fanghu Sun
Journal:  Strahlenther Onkol       Date:  2017-06-13       Impact factor: 3.621

7.  Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverine.

Authors:  Stefan Propping; Manfred Braeter; Marc-Oliver Grimm; Manfred P Wirth; Ursula Ravens; Melinda Wuest
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-02-25       Impact factor: 3.000

8.  Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways.

Authors:  J N Cornu; B Merlet; O Cussenot; G Cancel-Tassin; C Ciofu; G Amarenco; F Haab
Journal:  World J Urol       Date:  2010-07-14       Impact factor: 4.226

Review 9.  Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Correlation between Nocturia and Sleep: A Questionnaire Based Analysis.

Authors:  Seok Seon Yoo; Bong Suk Shim; Dong Hyeon Lee; Hyang Woon Lee; Hana Yoon
Journal:  Korean J Urol       Date:  2010-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.